Literature DB >> 7542497

Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.

B Mehrotra1, T I George, K Kavanau, H Avet-Loiseau, D Moore, C L Willman, M L Slovak, S Atwater, D R Head, M G Pallavicini.   

Abstract

Leukemia may be viewed as a clonal expansion of blast cells; however, the role of primitive cells and/or stem cells in disease etiology and progression is unclear. We investigated stem cell involvement in leukemia using fluorescence in situ hybridization (FISH), immunofluorescence labeling of hematopoietic subpopulations, and flow cytometric analysis/sorting to discriminate and quantify cytogenetically aberrant stem cells in 12 acute myeloid leukemia (AML) and three myelodysplastic (MDS) specimens. Flow cytometric analysis and sorting were used to discriminate and collect a primitive subpopulation enriched in stem cells expressing CD34+ and lacking CD33 and CD38 (CD34+lin-). A subpopulation containing progenitors and differentiating myeloid cells expressed CD34, CD33, and CD38 (CD34+lin+). Nine specimens contained less than 10% CD34+ cells and, thus, were considered to be CD34- leukemias. Mature lymphoid, myeloid, and erythroid subpopulations were sorted on the basis of antigen-linked immunofluorescence. Cytogenetically aberrant cells in sorted subpopulations were identified using FISH with enumerator probes selected on the basis of diagnosis karyotype. Cytogenetically aberrant CD34+lin- cells were present at frequencies between 9% and 99% in all specimens. CD34+lin- cytogenetically aberrant cells comprised between 0.05% and 11.9% of the marrow/blood specimens. Cytogenetically aberrant CD34+lin+ cells constituted 0.01% tp 56% of the marrow/blood population. These data demonstrate that aberrant cells are present in primitive CD34+ stem cell compartments, even in CD34- leukemias. Stem cell involvement was confirmed further by sorting lymphoid and erythroid subpopulations from eight specimens in which the predominant leukemic population lacked lymphoid/erythroid differentiation markers. In these specimens, as well as in multiple lineages, suggests involvement of a cell(s) with multilineage capabilities. The ability of aberrant CD34+lin- stem cells to contribute to clonal and compartment expansion within immunofluorescently defined subpopulations was evaluated to explore the functional phenotype of aberrant CD34+lin- cells. Analysis of compartment size and aberrant cell frequency suggests that frequency of cytogenetically aberrant stem cells is uncoupled from compartment size. These data suggest that cytogenetically aberrant cells in the primitive compartment show varying abilities to expand primitive compartments. Cytogenetically aberrant CD34+lin- cells precede the blast subpopulation in hierarchical maturation and may in some cases by considered preleukemic, requiring maturation or additional mutations before transformation (eg, compartmental expansion) occurs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542497

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  The paradox of response and survival in cancer therapeutics.

Authors:  Carol Ann Huff; William Matsui; B Douglas Smith; Richard J Jones
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 2.  Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies.

Authors:  Britta Will; Ulrich Steidl
Journal:  Best Pract Res Clin Haematol       Date:  2010-09       Impact factor: 3.020

3.  miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1.

Authors:  Xiaoqin Luo; Xian He; Xing Liu; Lunkun Zhong; Wenjian Hu
Journal:  Onco Targets Ther       Date:  2020-07-30       Impact factor: 4.147

4.  Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.

Authors:  Joshua E Allen; Lori S Hart; David T Dicker; Wenge Wang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2009-11-27       Impact factor: 4.742

Review 5.  Concise review: preleukemic stem cells: molecular biology and clinical implications of the precursors to leukemia stem cells.

Authors:  Ashley Pandolfi; Laura Barreyro; Ulrich Steidl
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

6.  Cbfbeta-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development.

Authors:  Ya-Huei Kuo; Rachel M Gerstein; Lucio H Castilla
Journal:  Blood       Date:  2007-10-16       Impact factor: 22.113

Review 7.  Hedgehog Signaling in the Maintenance of Cancer Stem Cells.

Authors:  Catherine R Cochrane; Anette Szczepny; D Neil Watkins; Jason E Cain
Journal:  Cancers (Basel)       Date:  2015-08-11       Impact factor: 6.639

Review 8.  The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models.

Authors:  James Neil Fisher; Natarajaswamy Kalleda; Vaia Stavropoulou; Juerg Schwaller
Journal:  Hemasphere       Date:  2019-01-30

9.  The miR-567/RPL15/TGF-β/Smad axis inhibits the stem-like properties and chemo-resistance of gastric cancer cells.

Authors:  Yuan Ma; Hua Xue; Weifeng Wang; Yaying Yuan; Fang Liang
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.